Bluetooth-Enabled ICD Find a Location Find a Doctor Heart & Vascular St. Elizabeth Implements First Bluetooth-Enabled Defibrillator A next-generation implantable cardiac defibrillator (ICD) with Bluetooth connectivity is now an option for patients at the St. Elizabeth Heart & Vascular Institute. St. Elizabeth was the first center in the nation to implant the Abbott Gallant biventricular ICD in September, 2020. The new device, recently FDA-approved as part of a new technology assessment, is available in only a few centers in the U.S. during this assessment phase. ICDs are implantable devices for patients who are at risk of life-threatening heart rhythm problems. This new ICD communicates wirelessly to the patient’s physician and also lets patients access information about the device using an app on a smartphone. The smartphone connectivity in this device is expected to substantially improve patient remote monitoring rates and patient engagement in monitoring. Research has shown that better patient engagement and compliance with monitoring translates into reduced hospitalizations, better clinical outcomes, and improvement in survival. The smartphone connectivity offers patients flexibility compared to traditional bedside monitors. The app allows easy transmission of data manually and access to device status such as battery longevity, all done securely in a cybersecure mode with enabled two-way authentication. For more information about this new device or for an appointment with a cardiac electrophysiologist who treats arrhythmias, contact the St. Elizabeth Arrhythmia Center at (859) 331-3353.